Keryx Biopharmaceuticals EV to EBIT (TTM)
View 4,000+ financial data types
Keryx Biopharmaceuticals EV to EBIT (TTM) Chart
Keryx Biopharmaceuticals Historical EV to EBIT (TTM) Data
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBIT
Enterprise value of a company divided by its Earnings Before Interest Taxes (TTM).
EV/EBIT answers the question "What is a company being valued per each dollar of EBIT?" A high (low) EV/EBIT mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/EBITDA : How much is each dollar of EBITDA worth to investors?
EV/Revenues : Or each dollar of Revenues?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
KERX EV to EBIT (TTM) Benchmarks
KERX EV to EBIT (TTM) Range, Past 5 Years
|Minimum||Upgrade||Dec 29 2009|
|Maximum||Upgrade||May 4 2010|
KERX EV to EBIT (TTM) Excel Add-In Codes
- Metric Code: ev_ebit
- Latest data point: =YCP("KERX", "ev_ebit")
- Last 5 data points: =YCS("KERX", "ev_ebit", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
GlobeNewswire 12/17 08:30 ET
GlobeNewswire 12/08 07:30 ET
Yahoo 12/05 12:00 ET
Yahoo 12/01 10:00 ET